Cardizem La Tablet, Extended Release
Product Images NDC 0187-2047

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Cardizem La (NDC 0187-2047). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch Health Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cardizem-la-image01 (Image 01)

FDA Label Image

Label 120mg

Cardizem LA is a medication containing diltiazem hydrochloride as the active ingredient. The tablets are extended-release and each contains 120mg of diltiazem. The usual dosage can be found in the package insert. The medication should be kept out of reach of children and stored in a tight, light-resistant container. It should be stored at a temperature of 25°C with excursions permitted from 15°C to 30°C. Cardizem LA is manufactured by Bausch Health Companies Inc. in Canada and distributed by Bausch Health US, LLC in the USA. This information is current as of 2019.*

FDA Label Image

Label 180mg

The Cardizem LA 180 mg tablet contains Diltiazem Hydrochloride and is an extended-release tablet intended for medical prescription only. The recommended dosage should be determined by a physician and the complete prescribing information can be found in the package insert accompanying the product. This medication must be stored in a tightly closed, light-resistant container and kept out of the reach of children. The recommended storage temperature is 25°C (77°F), although it is permissible to store it between 15° to 30°C (59° to 86°F). The product is manufactured by Bausch Health Companies Inc. of Canada and is distributed in the USA by Bausch Health US, LLC.*

FDA Label Image

Label 240mg

This is information for Cardizem LA, a medication that contains 240mg of Diltiazem Hydrochloride. The usual dosage is specified in the package insert. Cardizem LA should be kept out of reach of children and dispensed in a light-resistant container. It should be stored at 25°C and excursions are permitted between 15° to 30°C. Cardizem LA is manufactured for Bausch Health US, LLC in Bridgewater, NJ and manufactured by Bausch Health Companies Inc. in Steinbach, Canada. The product consists of 90 tablets and is a product of Canada.*

FDA Label Image

Label 300mg

Cardizem LA is a medicinal drug with a prescription for extended release tablets containing 300 mg of Diltiazem Hydrochloride. The package size includes 90 tablets, and the usual dosage is mentioned in the package insert for prescribing information. The drug must be kept out of reach of children and dispensed in a tightly closed container as defined in USP. Cardizem LA should be stored at a controlled room temperature of 25°C (77°F) with permitted excursions from 15° to 30°C (59° to 86°F). The drug is manufactured for Bausch Health US, LLC in Bridgewater, NJ 08807 USA, and manufactured by Bausch Health Companies Inc. in Steinbach, MB R5G 1Z7, Canada, and it is a product of Canada.*

FDA Label Image

Label 360mg

FDA Label Image

Label 420mg

CARDIZEM LA (Diltiazem Hydrochloride) Extended Release Tablets are prescribed medication in the form of 90 tablets. Each tablet contains Diltiazem Hydrochloride 420 mg. The usual dosage requires to check the package insert for prescribing information. The drug needs to dispense in tight, light-resistant containers and kept away from the reach of children. CARDIZEM LA must store in a temperature range of 15° to 30°C (59° to 86°F). Bausch Health US, LLC manufactures the drug in Bridgewater, NJ 08807, USA, and Bausch Health Companies Inc. in Steinbach, MB R5G 1Z7, Canada.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.